A 3D organoid bioassay was utilized to test the efficacy of the combination therapy in a panel of seven epithelial ovarian cancer cell lines and ten platinum‑resistant primary patient tumor samples.
[International Journal of Oncology]
Sorry, but the selected Zotpress account can't be found.
